Skip to main content
. 2023 Jun 1;14(3):858–878. doi: 10.14336/AD.2022.0916

Table 1.

The primary metabolites in the tryptophan pathway.

Substances Structural formula Functions in the Kynurenine pathway
TRP graphic file with name AD-14-3-858-g3.jpg The metabolic substrate of KP pathway
L-KYN 1. Neuroprotective effect
2. Immunosuppression, inhibition of the activity of natural killer cells, APC and DC [25]
3. Blocking T-cell proliferation and upregulation of regulatory T cells [43]
KYNA 1. Neuroprotective effect
2. A competitive antagonist of NMDA and AMPA [30]
3. Anti-inflammatory effect by stimulating GPR35 [34]
4. Immunosuppressive effect by activating AhR [37]
5. An antioxidant to remove ROS [31]
QUINA 1. Neural excitotoxicity [6]
2. Selective activation of NMDA receptors [8]
3. ROS formation and lipid peroxidation [29]
4. BBB disruption [47]
5. Upregulation of nitric oxide synthase and increases in neurotoxicity [93]
3-HK 1. The metabolite of L-KYN catalyzed by KMO
2. Neurotoxic effect
3. Producing free radicals and participating in the metabolism of oxidative stress and fat peroxidation [22]
3-HAA 1. The 3-HK metabolite catalyzed by Kynureninase
2. Neurotoxic effect
AA 1. The metabolite of L-KYN catalyzed by Kynureninase
2. Inhibition of 3-HAA metabolism in QUINA and PA, thus exhibiting a neuroprotective effect [161]

Abbreviations: 3-HAA: 3-hydroxyanthrenillc acid; 3-HK: 3-hydroxykynurenine; AA: anthranilic acid; AhR: aryl hydrocarbon receptor; AMPA: α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid; APC: antigen-presenting cells; BBB: blood-brain barrier; DC: dendritic cells; GPR35: G protein-coupled receptor 35; KMO: kynurenine 3-monooxygenase; KP: kynurenine pathway; KYNA: kynurenic acid; L-KYN: L-kynurenine; NMDA: N-methyl-D-aspartic acid; PA: picolinic acid; QUINA: quinolinic acid; ROS: reactive oxygen species; TRP: L-tryptophan.